The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

A new U.S. government study provides the most complete picture yet of early-onset cancers, defined as cancer diagnosed before ...

A new NIH-led study finds rising rates of 14 cancer types in Americans under 50, especially breast, colorectal, kidney, ...

Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

Recent studies have suggested that tattoos, chemical hair straighteners and even hot tea might be a problem. Here’s what an oncologist recommends.

Opdivo (nivolumab) is a brand-name IV infusion prescribed for non-small cell lung cancer (NSCLC) in some situations. This article covers topics such as side effects, dosage, and how Opdivo works.

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered in a new study in mice and humans by researchers at UCL ...

Cells expressing the basal cell marker KRT5 have been fluorescently labelled and can be seen spreading throughout the bronchial tree The ‘cell of origin’ of the second most common lung cancer ...